IHC analysis of the tumor tissues of the WT-RM-1-parent groups revealed that the combined treatment group exhibited significantly lower Ki67 expression levels compared to the control group and the groups that received individual treatment (P < 0.05) (Fig. 3A and B). The gene discussed is MKI67; the disease is neoplasm.